Researchers from The University of Texas MD Anderson Cancer Center have identified a new biomarker, TTF-1, that was ...

The landscape of neurology biomarkers has evolved significantly in recent years, affording new clinical insights that are ...

Many men with aggressive prostate cancer can experience a high rate of recurrence despite treatment.A new Phase 2 clinical ...

Researchers have identified C5aR1 as a novel biomarker for metastasis risk and poor prognosis in patients with cutaneous ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Wound assessment by medical professionals relies largely on visual inspection, which can be challenging due to its subjective ...

TURKU, FI / ACCESS Newswire / May 30, 2025 / Faron Pharmaceuticals (HEL:FARON)(LSE:FARN) - Phase I study shows promising clinical activity and tolerability of bexmarilimab plus standard-of-care in ...

The test could help direct prostate cancer patients to the best treatment option for them, researchers behind the findings ...

In a new study, researchers explored quantifying bile acids and tryptophan metabolites in human serum samples was created using ultrahigh-performance liquid chromatography coupled with tandem mass ...

Meaningful efficacy observed in slow-progressor subgroup; NfL biomarker improvements support potential for accelerated ...

Researchers have identified C5aR1 as a novel biomarker for metastasis risk and poor prognosis in patients with cutaneous ...

The test, developed by Artera, uses AI to pick up features invisible to the human eye on images of tumour samples.